Contribution of bone marrow–derived endothelial cells to human tumor vasculature
Top Cited Papers
- 20 February 2005
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 11 (3) , 261-262
- https://doi.org/10.1038/nm1200
Abstract
It has been shown that bone marrow–derived stem cells can form a major fraction of the tumor endothelium in mouse tumors. To determine the role of such cells in human tumor angiogenesis, we studied six individuals who developed cancers after bone marrow transplantation with donor cells derived from individuals of the opposite sex. By performing fluorescence in situ hybridization (FISH) with sex chromosome–specific probes in conjunction with fluorescent antibody staining, we found that such stem cells indeed contributed to tumor endothelium, but at low levels, averaging only 4.9% of the total. These results illustrate substantial differences between human tumors and many mouse models with respect to angiogenesis and have important implications for the translation of experimental antiangiogenic therapies to the clinic.Keywords
This publication has 13 references indexed in Scilit:
- Transplanted human bone marrow contributes to vascular endotheliumProceedings of the National Academy of Sciences, 2004
- CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancerJournal of Clinical Pathology, 2004
- Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytesNature, 2003
- Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumorsCancer Cell, 2003
- Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumorsCancer Cell, 2003
- A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapyBlood, 2003
- In VivoTargeting of Tumor Endothelial Cells by Systemic Delivery of Lentiviral VectorsHuman Gene Therapy, 2003
- Cell fusion is the principal source of bone-marrow-derived hepatocytesNature, 2003
- An Antigen Unmasking Protocol that Satisfies both Immunohistochemistry and Subsequent PCR AmplificationPathology - Research and Practice, 2003
- Origins of circulating endothelial cells and endothelial outgrowth from bloodJournal of Clinical Investigation, 2000